Rapid clearance of Plasmodium falciparum hyperparasitaemia after oral amodiaquine treatment in patients with uncomplicated malaria

Acta Tropica

Volumn 88, Issue 1, 2003, Pages 27-32

  Ndounga, Mathieu ^a,b   Basco, Leonardo K ^a,c  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b Centre d'Etudes sur les Ressources Végétales   (Congo)

^c Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

Author keywords

Chloroquine; Drug resistance; Drug treatment; Plasmodium falciparum

Indexed keywords

AMODIAQUINE;

DISEASE CONTROL; DRUG PRESCRIBING; HEALTH SERVICES; MALARIA;

ARTICLE; ASEXUAL REPRODUCTION; BLOOD; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; INFANT; MALARIA FALCIPARUM; MALE; PARASITE; PARASITEMIA; PATIENT; PATIENT MONITORING; PLASMODIUM FALCIPARUM; SMEAR; STANDARD; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

PLASMODIUM FALCIPARUM;

EID: 0041464677     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00174-8     Document Type: Article

References (14)

1. Basco L.K., Same-Ekobo A., Foumane Ngane V., Ndounga M., Metoh T., Ringwald P., Soula G. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bull. World Health Org. 80:2002;538-545.
2. Falade C.O., Salako L.A., Sowunmi A., Oduola A.M.J., Larcier P. Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans. R. Soc. Trop. Med. Hyg. 91:1997;58-62.
3. Luxemburger C., Ricci F., Nosten F., Raimond D., Bathet S., White N. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans. R. Soc. Trop. Med. Hyg. 91:1997;256-262.
4. Olliaro P., Nevill C., Le Bras J., Ringwald P., Mussano P., Garner P., Brasseur P. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet. 348:1996;1196-1201.
5. Price R., Luxemburger C., Van Vugt M., Nosten F., Kham A., Simpson J., Looareesuwan S., Chongsuphajaisiddhi T., White N.J. Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 92:1998;207-211.
6. Ringwald P., Keundjian A., Same Ekobo A., Basco L.K. Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon. Trop. Med. Int. Health. 5:2000;620-627.
7. Staedke S.G., Kamya M.R., Dorsey G., Gasasira A., Ndeezi G., Charlebois E.D., Rosenthal P.J. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet. 358:2001;368-374.
8. Warrell D.A., Looareesuwan S., Warrell M.J., Kasemsarn P., Intraprasert R., Bunnag D., Harinasuta T. Dexamethasone proves deleterious in cerebral malaria. A double blind trial in 100 comatose patients. New Engl. J. Med. 306:1982;313-319.
9. Warrell D.A., Molyneux M.E., Beales P.F. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84:1990;1-65.
10. White N.J. Why is it that antimalarial drug treatments do not always work. Ann. Trop. Med. Parasitol. 92:1998;449-458.
11. Winstanley P.A., Watkins W.M., Newton C.R.J.C., Nevill C., Mberu E., Warn P.A., Waruiru C.M., Mwangi I.N., Warrell D.A., Marsh K. The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. Br. J. Clin. Pharmacol. 33:1992;143-148.
12. World Health Organization, 1990. Practical chemotherapy of malaria. Technical Report Series No. 805, WHO, Geneva.
13. World Health Organization, 1996. Assessment of therapeutic efficacy for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL/96.1077.
14. World Health Organization, 2002. Monitoring antimalarial drug resistance. Report of a WHO consultation, Geneva, Switzerland, 3-5 December 2001, WHO/CDS/RBM/2002.39.